Джейн Плант - Ваша жизнь в ваших руках. Как понять, победить и предотвратить рак груди и яичников

28. McCusker, R.H., 1998. Controlling insulin-like growth factor activity and the modulation of insulin-like growth factor binding protein and receptor binding./. Dairy Sei., 81, 1790–1800.

29. The Institute of Food Science & Technology Position Statement

http:// www.easynet.co.uk/ifst/hottop8a.htm

30. Eppard, P.J. and others, 1985. Effect of dose of bovine growth hormone on milk consumption: alpha-lactalbumin, fatty acids and mineral elements./. Dairy Science Vol. 68 (11), pp. 3047–3054. See also Cohick, WS. and others, 1992. Regulation of insulin-like growth factor-binding proteins in serum and lymph of lactating cows by somatotropin. Endocrinology , 130(3), pp. 1508–1514.

31. Mepham, T.B. and others, 1994. Safety of Milk from Cows Treated with Bovine Somatotropin. Lancet , 334, November 19, 1445–1446 and Mepham, T.B. and Schonfield, P.N., 1995. Health Aspects of В ST Milk , prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

32. Simpson and others, http://www.nal.usda.gov/ttic/tekran/glimpse/data/000007/ 75/0000077539.html

33. Miller, M.A., Hildebrand, J.R., White, T.C., Hammond, E.G., Madson, K.S., and Collier, R.J., 1989. Determination of insulin-like growth factor-1 (IGF-1) concentrations in raw pasteurised and heat treated milk. Journal of Dairy Science , 72, Supplement 1, 186–187.

34. Hankinson, Susan E. and others, 1998. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 351, 9113, 9 May, 1393–1396.

35. Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk; A Prospective Study. Science , 279, January.

36. Pollack, M.N., Huynh, H.T. and Lefebvre, S.P., 1992. Tamoxifen reduces serum insulin-like growth factor 1 (IGF-1). Br Cancer Res Treat, 22,91-100.

37. Pollack, M.N. and others, 1998. IGF-1 Risk Factor for Prostate Cancer. Science , 279, 563–566.

38. Chan and others, 1998. Plasma IGF-1 and Prostate Cancer Risk: A Prospective Study. Science , 279, January.

39. Holly, Jeff, 1998. Insulin-like growth factor-1 and new opportunities for cancer prevention. Lancet , 351, 9113, 9 May, 1373–1375.

40. Epstein, Samuel S., 1996. Unlabelled Milk from Cows Treated with Biosynthetic Growth Hormones: A Case of Regulatory Abdication. International Journal of Health Services , 26, 1, 173–185.

41. Outwater, J. L., Nicholson A. and Bernard N., 1997. Dairy products and breast cancer: the IGF-1, estrogen, and bGH hypothesis. Medical Hypotheses 48, 453–461.

42. Leonard, Rodney E., 1995. Codex at the Crossroads: Conflict on Trade Health. Nutrition Week , Vol. 25, № 26, 14 July, pp. 4–5, Nutrition Week is published by the Community Nutrition Institute, 910 17 thStreet, N.W, Suite 413, Washington DC 20006.

43. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions, http://europa.eu. mt/comm/dg24/health/ sc/scv/ out 19_en.html

44. D’Ercole, J.A., Underwood, L.E. and Van Wyk, J.J., 1977. Serum Somatomedin-C in hypopituaritism and in other disorders of growth./. Pediatr , 90, 3, 375–381. See also Cullen, K.J. and others, 1990. Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Research , vol. 50, pp. 48–53.

45. De Leon, D.D., Wilson, D.M., Powers, M. and Rosenfeld, R.G., 1992. Effects of insulin-like growth factors (IGFs) and IGF receptor antibodies on the proliferation of human breast cancer cells. Growth Factors , 6, 327–336.

46. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer , 29A, 4, 492–497.

47. Peyrat, J.P., Bonneterre, J. and Hecquet, B. and others, 1993. Plasma insulin-like growth factor 1 (IGF-1) concentrations in human breast cancer. Eur J Cancer , 29A, 4, 492–497.

48. Musgrove, E.A. and Sutherland, R.I., 1993. Acute effects of growth factors on T471 breast cancer cell cycle progression, Eur J Cancer , 29 A, 16, 2273–2279.

49. Heldrin, C.N. and Westermark, B., 1984. Growth factors: mechanism of action and relation to oncogenes. Cell , 37:9, 20.

50. Macaulay, V. М., 1992. Insulin-like growth factors and cancer. Br J Cancer , 65, 311–320.

51. Underwood, L.E., D’Ercole, J.A. and Van Wyk, J.J., 1980. So-matomedin-C and the assessment of growth. Fed ClinN Amer,

27, 4, 771–782, and Perdue, J.F., 1984. Chemistry, structure and function of insulin-like growth factors and their receptors: a review. Can J Biochem Cell Bio., 62, 1237–1245.

52. Outwater, J.L., Nicholson, A, and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses , 48, 453–461.

53. The European Commission. Health and Consumer Protection. Scientific Committee on Veterinary Measures relating 10 Public Health – Outcome of discussions. http://europa.eu.int/comm/dg24/health/ sc/scv/ outl 9_en.html

54. Council on Scientific Affairs, American Medical Association, Biotechnology and the American Agricultural Industry, 1991. Journal of the American Medical Association (JAMA), 265, 11, 20 March, p. 1433.

55. Mepham, T.B. and Schonfield, P.N., 1995. Health Aspects of BST Milk, prepared for the International Dairy Federation Nutrition Week conference in Paris, France, June 1995.

56. Challacombe. D.N. and Wheeler, E.E., 1994. Safety of milk from cows treated with bovine somatotropin. Lancet , 344, 17 September, p. 815.

57. Sell, C., Rubin, R. and Baserga, R., 1995. Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-in-duced apoptosis. Cancer Research, Jan 15, 55(2), 303–306.

58. Burton, Jeanne L. and others, 1994. A review of bovine growth hormone, Canadian Journal of Animal Science , 74, 167–201.

59. Xian, C., 1995. Degradation of IGF-1 in the Adult Rat Gastrointestinal Tract is limited by a Specific Antiserum of the Dietary Protein Casein .Journal of Endocrinology , 146, 2, 1 August, p. 215, and Thornburg, W and others, 1984. Gastrointestinal absorption of epidermal growth factor in suckling rats. American Journal of Physiology , 246, G80-G85.

60. Outwater, J.L., Nicholson, A. and Barnard, N., 1997. Dairy products and breast cancer; the IGF-1 estrogen, and bGH hypothesis. Medical Hypotheses , 48, 453–461.

61. Harasuchi, S., Good, R.A., Engelman, R.W and Day, N.K., 1992. Human prolactin regulates transfected MMTV LTR-di-rected gene expression in a human breast-carcinoma cell line through synergistic interaction with steroid hormones. Int J Cancer , 52, 923–933.

62. Clevenger, C,V, Chang, WF., Ngo, W, Pasha, T.L., Montone, K.T. And Tomaszewski, J. E., 1995. Expression of prolactin and prolactin receptor in human breast carcinoma. Evidence for an autocrine/paracrine loop .Am J Pathol, 146, 695–705.

63. Vonderhaar B.K., 1989. Estrogens are not required for prolactin induced growth of MCF-7 human breast cancer cells. Cancer Lett, A7, 105–110.

64. http://www.shef.ac.uk/uni/academic/a-c/csi/1997/pir2.html

65. Lochnan, H.A. and others, 1995. Functional activity of the human prolactin receptor and its ligands. Mol. Cell. Endocrinol, 114, 91–99.

66. http://mammary.nih.20v/reviews/tumorigenesis/Vonderhaar 001/ slides/introduction.html

67. Struman, I., Bentzien, F., Lee, H., Mainfroid, V, D’Angelo, G., Goffin, V., Weiner, R.I. and Martial, J.A., 1999. Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sei USA, 96, 1246–1251.